维普中文期刊产品整合服务
60篇 您的检索式:作者名="Craxi A"
    题名 作者 年代 出处 被引量
12011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines显示文摘Calvaruso V Craxi A 2012Liver Int2012,32,1:1
2Epidemiology, risk factors and surveillance of bepatocellular carcinoma显示文摘Cabibbo G Craxi A 2010Eur Rev Med Pharmacol Sci2010,14,4:1
3Optimizing the treatment of chronic hepatitis due to hepatitis C virus genotypes 2 and 3: a review显示文摘Tarantino G Craxi A 2009Liver Int2009,29,1:1
4Treatment Options in HBV显示文摘CRAXI A ANTONUCCI G CAMMA C 2006J Hepatol(S0168-8278)2006,44,1:1
5EASL Clinical Practice Guidelines : Management of hepa- titis C virus infection显示文摘Craxi A 2011J 14epato12011,28,:1
6Diagnostic approach to liver enzyme elevation显示文摘Craxi A Almasio P 1996J Hepatol1996,25,1:1
7Diagnostic approach to liver enzyme elevation 显示文摘Craxi A Ahnasio P 1996Hepatol1996,,:1
8Non-alcoholic fatty liver dis-ease pathogenesis: the present and the future 显示文摘Petta S Muratore C Craxi A 2009Dig LiverDis2009,41,9:1
9Non-alcoholic fatty liver disease pathogenesis: The present and the future 显示文摘Petta S Muratore C Craxi A 2009Digestive and Liver Disease2009,41,9:1
10Diagnostic approach to liver enzyme elevation 显示文摘Craxi A Almasio P 1996J Hepatol1996,,:1
11Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response 显示文摘Pagliaro L Craxi A Cammaa C 1994Hepatology1994,19,4:1
12Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection 显示文摘Fried MW Shiffman ML Reddy KR Smith C Marinos G Goncales FL Jr H/iussinger D Diago M Carosi G Dhumeaux D Craxi A Lin A Hoffman J Yu J 2002N Engl J Med2002,347,13:1
13Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association显示文摘Petta S Craxi A 2010Curr Pharm Des2010,16,:1
14Epidemiology, risk factors and surveillance of hepatoeellular carcinoma显示文摘Cabibbo G Craxi A 2010Eur Rev Med Pharmacol Sci2010,14,4:1
15Pegylated interferons for chronic hepatitis B显示文摘Craxi A Cooksley WG 2003Antiviral Res2003,60,:1
16Hepatitis C viremia in chronic liver disease:relationship to interferon-alpha or corticosteroid treatment 显示文摘MAGRIN S CRAXI A FABIANO C 1994Hepatology1994,19,:1
17Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection 显示文摘Fried MW Shiffman ML Reddy KR Smith C Marinos G Goncales FL Jr Haussinger D Diago M Carosi G Dhumeaux D Craxi A Lin A Hoffman J Yu J 2002N Engl J Med2002,347,3:1
18Which patients with genotype I chronic hepatitis C can benefit from prolonged treatment with the 'accordion' regimen? 显示文摘Marcellin P Heathcote E J Craxi A 2007J Hepatol2007,47,4:1
19Epidemiology, risk factors and surveillance of hepatocellular carcinoma显示文摘Cabibbo G Craxi A 2010Eur Rev Med Pharmacol Sci2010,14,4:1
202011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines显示文摘Calvaruso V Craxi A 2012Liver Int2012,32,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费